• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MCKESSON MEDICAL-SURGICAL INC XEROFORM DRESSING; DRESSING, WOUND, DRUG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MCKESSON MEDICAL-SURGICAL INC XEROFORM DRESSING; DRESSING, WOUND, DRUG Back to Search Results
Lot Number 09237
Health Effect - Clinical Codes Itching Sensation (1943); Blister (4537); Skin Burning Sensation (4540); Skin Inflammation/ Irritation (4545)
Date of Event 01/22/2025
Type of Reportable Event Serious Injury
Event or Problem Description
Had surgery for baxter's nerve release.Xeroform dressing was applied to surgical site on (b)(6) 2025.One week later it resulted in a rash in the area the xeroform dressing was applied.The rash blistered.Felt like burning and had uncontrollable itching.Diphenhydramine was used with little to no effect.Ice applied to the area to reduce burning feeling and distract from itching.No tests were performed.Evaluation done by pa when dressings were removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XEROFORM DRESSING
Common Device Name
DRESSING, WOUND, DRUG
Manufacturer (Section D)
MCKESSON MEDICAL-SURGICAL INC
9954 mayland drive
richmond VA 23233
MDR Report Key21422163
Report NumberMW5166541
Device Sequence Number4209952
Product Code FRO
Combination Product (Y/N)N
Initial Reporter StateOR
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Patient
Type of Report Initial
Report Date (Section B) 02/14/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Lot Number09237
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date02/20/2025
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ACETAMINOPHEN; IBUPROFEN
Patient Age1 MO
Patient SexFemale
Patient Weight116 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-